DC120, a novel AKT inhibitor, preferentially suppresses nasopharyngeal carcinoma cancer stem-like cells by downregulating Sox2

Juan Qin(Sun Yat-sen University Cancer Center), Xiao‐Feng Zhu(Sun Yat-sen University)
Oncotarget
February 4, 2015
Cited by 37


Related Papers